Dr. Jeffrey R. Jay, M.D. »

Ocuphire Pharma shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 324k 4.55

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Vor Biopharma Com New (VOR)
Zura Bio Class A Ord Shs (ZURA)
Amylyx Pharmaceuticals (AMLX)
Immunitybio Put Option (IBRX)
Nektar Therapeutics Com New (NKTR)
Sol-gel Technologies Shs New (SLGL)
Alumis (ALMS)
Bright Minds Biosciences Com New (DRUG)
Annexon (ANNX)
Kalvista Pharmaceuticals (KALV)
Immunovant (IMVT)
Jade Biosciences Com New (JBIO)
Contineum Therapeutics Cl A (CTNM)
Zenas Biopharma (ZBIO)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Ocuphire Pharma

BIOS Capital Management
Balyasny Asset Management
Millennium Management
Vanguard Capital Management
Vanguard Group
ADAR1 Capital Management
Perceptive Advisors
Nantahala Capital Management
Woodline Partners
Boothbay Fund Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Mink Brook Asset Management
Geode Capital Management

View all funds holding Ocuphire Pharma